Cenk Yücel Bilen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cenk Yücel Bilen has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Hakan Bahadir Haberal
Department of Urology, Ankara Etlik City Hospital, Ministry of Health, University of Health Sciences, Ankara, Turkiye
7 shared publications - Sertac Yazici
Department of Urology, School of Medicine, Hacettepe University, Ankara 06800, Türkiye
6 shared publications - Ali Ergen
Hacettepe Univ, Dept Urol, Fac Med, Ankara, Turkey
4 shared publications - Ahmet Gudeloglu
Department of Urology, Hacettepe University Faculty of Medicine, Ankara, Turkey
3 shared publications - Meylis Artykov
Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey
3 shared publications - Berk Hazir
Department of Urology, Hacettepe University School of Medicine, Ankara, Turkey
2 shared publications
Latest Publications
- 5 June 2023
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 10 (2) , 139-146
Risk Factors for Complications in Simple Nephrectomy: 17-Year Results from Single Institution
- 5 June 2023
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 10 (2) , 139-146
Risk Factors for Complications in Simple Nephrectomy: 17-Year Results from Single Institution
- Open Access
- 21 December 2022
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 28 (6) , 597-602
Endovascular management of renal angiomyolipomas: Do coils have a benefit in terms of clinical success rates?
This study evaluated single-center results of endovascular treatment in renal angiomyolipoma (AML) to determine whether there is clinical relevance of adding proximal coil embolization to distal particle embolization in terms of safety, efficacy, and retreatment rates. A retrospective analysis was performed to evaluate patients undergoing transarterial embolization for renal AMLs from January 2007 to October 2020. Parameters regarding patient and tumor characteristics, embolization technique, treatment outcome, and complications were recorded. Patients were divided into 2 groups as A (only particle group) and B (particle + coil group) based on the type of embolic agent used for treatment. Comparative analysis was performed between the 2 groups in terms of tumor size reduction, retreatment, and complication rates. In this study, 42 patients (37 (88.1%) females and 5 (11.9%) males) harboring 48 AMLs were included. The mean age was 43.46 (range, 20-78). The technical success rate was 95.8% (46 of 48 procedures). The mean size reduction was 1.94 ± 1 cm (P < .001) after treatments; however, no significant difference was seen between groups in terms of tumor size reduction. Retreatment rates were 3.1% (1 of 32 cases) in group A and 14.3% (2 of 14 cases) in group B (P = .21). No significant difference was found between groups in terms of bleeding and complication rates during the perioperative period. Mean follow-up duration was 26.48 ± 25.71 (range, 2-102) months. In this study, no clear supplementary benefit was observed in terms of safety and efficacy with the adjunction of coils to distal particle embolization in the management of AMLs.
- 21 December 2022
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 28 (6) , 597-602
Open AccessEndovascular management of renal angiomyolipomas: Do coils have a benefit in terms of clinical success rates?
This study evaluated single-center results of endovascular treatment in renal angiomyolipoma (AML) to determine whether there is clinical relevance of adding proximal coil embolization to distal particle embolization in terms of safety, efficacy, and retreatment rates. A retrospective analysis was performed to evaluate patients undergoing transarterial embolization for renal AMLs from January 2007 to October 2020. Parameters regarding patient and tumor characteristics, embolization technique, treatment outcome, and complications were recorded. Patients were divided into 2 groups as A (only particle group) and B (particle + coil group) based on the type of embolic agent used for treatment. Comparative analysis was performed between the 2 groups in terms of tumor size reduction, retreatment, and complication rates. In this study, 42 patients (37 (88.1%) females and 5 (11.9%) males) harboring 48 AMLs were included. The mean age was 43.46 (range, 20-78). The technical success rate was 95.8% (46 of 48 procedures). The mean size reduction was 1.94 ± 1 cm (P < .001) after treatments; however, no significant difference was seen between groups in terms of tumor size reduction. Retreatment rates were 3.1% (1 of 32 cases) in group A and 14.3% (2 of 14 cases) in group B (P = .21). No significant difference was found between groups in terms of bleeding and complication rates during the perioperative period. Mean follow-up duration was 26.48 ± 25.71 (range, 2-102) months. In this study, no clear supplementary benefit was observed in terms of safety and efficacy with the adjunction of coils to distal particle embolization in the management of AMLs.
- Open Access
- 1 May 2022
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 32 (05) , 565-569
Safety of Minimally Invasive Surgical Techniques in Large Adrenal Lesions: A Single-Centre Study
To compare perioperative outcomes of minimally invasive surgery for ≥5 cm and <5 cm adrenal lesions. Retrospective cohort study. Hacettepe University School of Medicine, Ankara, Turkey, between October 2007 and September 2019. Data of 83 patients operated for adrenal lesions was collected retrospectively. Patients were categorized into two groups based on the size of the adrenal gland as <5 cm and ≥5 cm. The groups were compared in terms of perioperative outcomes. The median age of the patients was 51 (41-60) years, with a female-to-male ratio of 27/56. The median follow-up period was 27 (11.5-91) months. Of 83 adrenal masses, 60 (72.3%) were in the <5 cm group and 23 (27.7%) were in the ≥5 cm group. Fifteen (18.1%) patients underwent adrenalectomy for lung cancer metastasis, whereas three (3.6%) for renal cell carcinoma metastasis. The overall rate of post-operative complications was 10.8%. Post-operative complication rates were similar in each group (p=0.433). Operation time was found to be significantly higher in patients with large adrenal masses (p=0.003). Minimally invasive surgical techniques have the same perioperative results in the group with adrenal lesions ≥5 cm compared to <5 cm and may be safely employed in this group of patients. Laparoscopy, Robotic assisted laparoscopy, Adrenalectomy, Metastasectomy, Adrenal gland neoplasms.
- 1 May 2022
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 32 (05) , 565-569
Open AccessSafety of Minimally Invasive Surgical Techniques in Large Adrenal Lesions: A Single-Centre Study
To compare perioperative outcomes of minimally invasive surgery for ≥5 cm and <5 cm adrenal lesions. Retrospective cohort study. Hacettepe University School of Medicine, Ankara, Turkey, between October 2007 and September 2019. Data of 83 patients operated for adrenal lesions was collected retrospectively. Patients were categorized into two groups based on the size of the adrenal gland as <5 cm and ≥5 cm. The groups were compared in terms of perioperative outcomes. The median age of the patients was 51 (41-60) years, with a female-to-male ratio of 27/56. The median follow-up period was 27 (11.5-91) months. Of 83 adrenal masses, 60 (72.3%) were in the <5 cm group and 23 (27.7%) were in the ≥5 cm group. Fifteen (18.1%) patients underwent adrenalectomy for lung cancer metastasis, whereas three (3.6%) for renal cell carcinoma metastasis. The overall rate of post-operative complications was 10.8%. Post-operative complication rates were similar in each group (p=0.433). Operation time was found to be significantly higher in patients with large adrenal masses (p=0.003). Minimally invasive surgical techniques have the same perioperative results in the group with adrenal lesions ≥5 cm compared to <5 cm and may be safely employed in this group of patients. Laparoscopy, Robotic assisted laparoscopy, Adrenalectomy, Metastasectomy, Adrenal gland neoplasms.
- Open Access
- 1 December 2021
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 8 (4) , 243-247
Variant Histology: The Impact on Oncological Outcomes of Patients with Urothelial Carcinoma of The Bladder Treated with Radical Cystectomy
- 1 December 2021
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 8 (4) , 243-247
Open AccessVariant Histology: The Impact on Oncological Outcomes of Patients with Urothelial Carcinoma of The Bladder Treated with Radical Cystectomy
- 22 April 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (7) , e14243
Changes in percutaneous approach to kidney stones in children: A single institute experience over 500 cases
Purpose The aim of this study is to identify the changes in patient age and stone sizes with technological advancement over time. Methods This study was conducted retrospectively with 404 patients (504 renal units) who underwent percutaneous nephrolithotomy (PCNL) between January 1997 and June 2020. Patient characteristics and trends on instrument preferences were investigated. Results Median age was 7 (1‐18) years. Male to female ratio was 1.48:1 (301/203). Median stone burden was 2 cm2 (0.20−25) and median operative time was 90 minutes (20‐240). The stone‐free rate was 74.6%. Patients were divided into four groups according to the size of the instrument. It was found that the size of sheath used increased significantly with increasing age and stone burden. The micro‐PCNL group had the shortest hospitalisation and lowest blood transfusion rate. Chronologically categorised four equal groups were compared to analyse changing patient profiles and trends. Median patient age, stone burden, operation time, sheath size, blood transfusion and complication rates decreased significantly with time. However, the use of tracts smaller than 20F and the number of patients with previous intervention increased significantly. Conclusion Our study demonstrated that the patient's age and stone size at the time of initial diagnosis decrease over time while miniaturisation techniques increase in paediatric urology.
- 22 April 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (7) , e14243
Changes in percutaneous approach to kidney stones in children: A single institute experience over 500 cases
Purpose The aim of this study is to identify the changes in patient age and stone sizes with technological advancement over time. Methods This study was conducted retrospectively with 404 patients (504 renal units) who underwent percutaneous nephrolithotomy (PCNL) between January 1997 and June 2020. Patient characteristics and trends on instrument preferences were investigated. Results Median age was 7 (1‐18) years. Male to female ratio was 1.48:1 (301/203). Median stone burden was 2 cm2 (0.20−25) and median operative time was 90 minutes (20‐240). The stone‐free rate was 74.6%. Patients were divided into four groups according to the size of the instrument. It was found that the size of sheath used increased significantly with increasing age and stone burden. The micro‐PCNL group had the shortest hospitalisation and lowest blood transfusion rate. Chronologically categorised four equal groups were compared to analyse changing patient profiles and trends. Median patient age, stone burden, operation time, sheath size, blood transfusion and complication rates decreased significantly with time. However, the use of tracts smaller than 20F and the number of patients with previous intervention increased significantly. Conclusion Our study demonstrated that the patient's age and stone size at the time of initial diagnosis decrease over time while miniaturisation techniques increase in paediatric urology.
- 1 December 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (4) , 218-219
Robotic Seminal Vesicle Surgery: The Key Steps
- 1 December 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (4) , 218-219
Robotic Seminal Vesicle Surgery: The Key Steps
- 5 June 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (2) , 60-63
A Technical Modification to Reduce Potential Contamination in Transperineal Prostate Fusion Biopsy
- 5 June 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (2) , 60-63
A Technical Modification to Reduce Potential Contamination in Transperineal Prostate Fusion Biopsy
- Open Access
- 3 December 2018
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 57 (4) , 218-221
The efficacy of sakral neuromodulation and effects on quality of life in women
En tr Aim: We aimed to determine the efficacy of sacral neuromodulation (SNM) and affects on health-related quality of life in women. Materials and Methods: The records of patients undergone SNM at Hacettepe University Hospital between 1999 and 2016 were analyzed. Female patients with a successful SNM procedure who were placed permanent battery were included the study. Both the SNM patients and the control group were administered the Turkish validated version of the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) questionnaire and adapted to the scored form of BFLUTS. Results: In total 35 patients had undergone SNM. Among these patients, a total of 19 female patients who had been tested successfully and were placed permanent batteries were sent a questionnaire and 9 women who answered the questionnaire were included in the study. The control group consisted of 18 female patients. The mean age of the SNM patients was 46.7±12.8 years, while the mean age of the control group was 44.2±8.2 years. There was no significant difference between the groups in terms of age (p=0.544). Filling and voiding symptoms were more frequent in the SNM patient group, whereas incontinence symptoms were similar in the SNM patients and control group. There was no deterioration in sexual function of SNM patients compared to controls. The quality of life of SNM patients was significantly lower than the control group. Conclusion: SNM would be the choice of treatment for patients with lower urinary tract dysfunction. Urinary incontinence and sexual functions of female patients who underwent SNM treatment are similar to adults of the same age group. Amaç: Kadın hastalarda sakral nöromodülasyon (SNM) işleminin etkinliğini ve sağlıkla ilişkili yaşam kalitesi üzerine etkisini ortaya koymayı amaçladık. Gereç ve Yöntem: Hacettepe Üniversitesi Hastanesinde 1999-2016 tarihleri arasında SNM işlemi yapılan hastaların verileri retrospektif olarak değerlendirildi. SNM işlemi başarılı olan ve kalıcı pil yerleştirilen kadın hastalar çalışmaya dahil edildi. Hem SNM hastalarına hem de kontrol grubuna Bristol Female Lower Urinary Tract Symptoms (BFLUTS) anketinin Türkçe geçerliliği yapılmış şekli uygulandı ve BFLUTS’un skorlanmış formuna uyarlandı. Bulgular: SNM işlemi uygulanan toplam hasta sayısı 35 idi. Bu hastalar içinden testi başarılı olan ve kalıcı pil yerleştirilen toplam 19 kadın hastaya anket formu gönderildi ve ankete cevap veren 9 kadın çalışmaya dahil edildi. Kontrol grubunu 18 kadın hasta oluşturdu. SNM hastalarının ortalama yaşı 46.7±12.8 yıl iken kontrol grubunun ortalama yaşı 44.2±8.2 yıl olup gruplar arasında yaş açısından anlamlı farklılık bulunmamakta idi ( p= 0.544). Dolum ve işeme semptomları SNM hasta grubunda daha sık gözlenirken inkontinans semptomları SNM hastaları ve kontrol grubunda benzerdi. SNM hastalarının seksüel fonksiyonlarında kontrol grubundakilere göre bir kötüleşme saptanmadı. SNM hastalarının yaşam kaliteleri kontrol grubuna göre anlamlı olarak azalmış bulundu. Sonuç: SNM işlemi alt üriner sistem disfonksiyonu (AÜSD) olan hastalarda tercih edilebilecek bir tedavi yöntemidir. SNM işlemi geçiren kadın hastaların idrar kaçırma durumları ve seksüel fonksiyonları aynı yaş grubundaki erişkinler ile benzerlik göstermektedir .
- 3 December 2018
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 57 (4) , 218-221
Open AccessThe efficacy of sakral neuromodulation and effects on quality of life in women
En tr Aim: We aimed to determine the efficacy of sacral neuromodulation (SNM) and affects on health-related quality of life in women. Materials and Methods: The records of patients undergone SNM at Hacettepe University Hospital between 1999 and 2016 were analyzed. Female patients with a successful SNM procedure who were placed permanent battery were included the study. Both the SNM patients and the control group were administered the Turkish validated version of the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) questionnaire and adapted to the scored form of BFLUTS. Results: In total 35 patients had undergone SNM. Among these patients, a total of 19 female patients who had been tested successfully and were placed permanent batteries were sent a questionnaire and 9 women who answered the questionnaire were included in the study. The control group consisted of 18 female patients. The mean age of the SNM patients was 46.7±12.8 years, while the mean age of the control group was 44.2±8.2 years. There was no significant difference between the groups in terms of age (p=0.544). Filling and voiding symptoms were more frequent in the SNM patient group, whereas incontinence symptoms were similar in the SNM patients and control group. There was no deterioration in sexual function of SNM patients compared to controls. The quality of life of SNM patients was significantly lower than the control group. Conclusion: SNM would be the choice of treatment for patients with lower urinary tract dysfunction. Urinary incontinence and sexual functions of female patients who underwent SNM treatment are similar to adults of the same age group. Amaç: Kadın hastalarda sakral nöromodülasyon (SNM) işleminin etkinliğini ve sağlıkla ilişkili yaşam kalitesi üzerine etkisini ortaya koymayı amaçladık. Gereç ve Yöntem: Hacettepe Üniversitesi Hastanesinde 1999-2016 tarihleri arasında SNM işlemi yapılan hastaların verileri retrospektif olarak değerlendirildi. SNM işlemi başarılı olan ve kalıcı pil yerleştirilen kadın hastalar çalışmaya dahil edildi. Hem SNM hastalarına hem de kontrol grubuna Bristol Female Lower Urinary Tract Symptoms (BFLUTS) anketinin Türkçe geçerliliği yapılmış şekli uygulandı ve BFLUTS’un skorlanmış formuna uyarlandı. Bulgular: SNM işlemi uygulanan toplam hasta sayısı 35 idi. Bu hastalar içinden testi başarılı olan ve kalıcı pil yerleştirilen toplam 19 kadın hastaya anket formu gönderildi ve ankete cevap veren 9 kadın çalışmaya dahil edildi. Kontrol grubunu 18 kadın hasta oluşturdu. SNM hastalarının ortalama yaşı 46.7±12.8 yıl iken kontrol grubunun ortalama yaşı 44.2±8.2 yıl olup gruplar arasında yaş açısından anlamlı farklılık bulunmamakta idi ( p= 0.544). Dolum ve işeme semptomları SNM hasta grubunda daha sık gözlenirken inkontinans semptomları SNM hastaları ve kontrol grubunda benzerdi. SNM hastalarının seksüel fonksiyonlarında kontrol grubundakilere göre bir kötüleşme saptanmadı. SNM hastalarının yaşam kaliteleri kontrol grubuna göre anlamlı olarak azalmış bulundu. Sonuç: SNM işlemi alt üriner sistem disfonksiyonu (AÜSD) olan hastalarda tercih edilebilecek bir tedavi yöntemidir. SNM işlemi geçiren kadın hastaların idrar kaçırma durumları ve seksüel fonksiyonları aynı yaş grubundaki erişkinler ile benzerlik göstermektedir .
- Open Access
- 1 January 2017
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 5
Long-standing aggressive angiomyxoma as a paratesticular mass: A case report and review of literature
Objectives: Aggressive angiomyxoma is known as a mesenchymal tumor of premenopausal women and it is extremely rare in men. Methods: Herein, we report a 66-year-old male with a firm scrotal mass that had gradually enlarged over 20 years. Results: Radiological studies revealed 10 x 15 cm mass lesion confined to right scrotum with neither local invasion nor distant metastasis. Inguinal orchiectomy was performed and histopathology showed characteristic features of an aggressive angiomyxoma occupying paratesticular region, which was a challenging diagnosis due to its unexpected occurrence in the male gender. Conclusion: Aggressive angiomyxoma is mostly considered as a benign tumor in females despite its propensity for local recurrence. Whether it may show a divergent biological behavior in men is unknown as the reported cases are too few.
- 1 January 2017
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 5
Open AccessLong-standing aggressive angiomyxoma as a paratesticular mass: A case report and review of literature
Objectives: Aggressive angiomyxoma is known as a mesenchymal tumor of premenopausal women and it is extremely rare in men. Methods: Herein, we report a 66-year-old male with a firm scrotal mass that had gradually enlarged over 20 years. Results: Radiological studies revealed 10 x 15 cm mass lesion confined to right scrotum with neither local invasion nor distant metastasis. Inguinal orchiectomy was performed and histopathology showed characteristic features of an aggressive angiomyxoma occupying paratesticular region, which was a challenging diagnosis due to its unexpected occurrence in the male gender. Conclusion: Aggressive angiomyxoma is mostly considered as a benign tumor in females despite its propensity for local recurrence. Whether it may show a divergent biological behavior in men is unknown as the reported cases are too few.
- Open Access
- 29 September 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1673
Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?
To study whether −160 C > A (rs16260) and −347 G > GA (rs5030625) single nucleotide polymorphisms of the regulatory region (rSNPs) of CDH1 gene modulate the risk of nephrolithiasis. Genomic DNA of 101 patients with calcium oxalate nephrolithiasis and 114 healthy controls were screened for both polymorphisms, using polymerase chain reaction-restriction fragments length polymorphism method (PCR-RLFP). Haplotype frequencies were also analyzed. To determine the association of rSNPs of CDH1 gene with the clinicopathological features of nephrolithiasis, nearly all possible etiological factors were documented. These factors were family history, gender, age, body mass index, liquid consumption, eating habits, tea–coffee and meat (oxalate rich) consumption, adequate physical activity, and all serum and urine levels—the serum levels of Na, K, Cl, phosphate, Ca, Mg, uric acid, albumin, blood urea nitrogen (BUN), creatinine and serum parathyroid hormone (PTH) as well as 24 h urine excretions of creatinine, Na, K, Cl, phosphate, Ca, Mg, citrate, oxalate, uric acid, albumin and BUN. Significant differences were found between rs16260 and the risk of nephrolithiasis. Patients having CA genotype of rs16260 CDH1 polymorphism were associated with an almost trifold increased risk for developing kidney stone than those with the AA genotype (95 % CI 1.08–7.28, OR 2.8, P = 0.033). We also found that non-A allele carriers (CC) had significantly higher nephrolithiasis risk associated with the clinicopathological characteristics including serum calcium (P = 0.027) and 24 h urinary magnesium level (P = 0.042). Moreover, we did find a directly proportional relationship between the CA genotype and serum calcium levels (P = 0.041). There was no significant difference between patients and controls in terms of the distribution of rs5030625 genotypes and alleles (P > 0.05). Likewise, no associations between the rs16260 and rs5030625 haplotypes and susceptibility to kidney stone were observed (P > 0.05). Regulatory variants of rs16260 of the CDH1 gene may confer susceptibility to nephrolithiasis. This may have important implications for understanding the pathophysiological mechanisms of the disease and suggesting novel targets for drug treatment.
- 29 September 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1673
Open AccessMight E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?
To study whether −160 C > A (rs16260) and −347 G > GA (rs5030625) single nucleotide polymorphisms of the regulatory region (rSNPs) of CDH1 gene modulate the risk of nephrolithiasis. Genomic DNA of 101 patients with calcium oxalate nephrolithiasis and 114 healthy controls were screened for both polymorphisms, using polymerase chain reaction-restriction fragments length polymorphism method (PCR-RLFP). Haplotype frequencies were also analyzed. To determine the association of rSNPs of CDH1 gene with the clinicopathological features of nephrolithiasis, nearly all possible etiological factors were documented. These factors were family history, gender, age, body mass index, liquid consumption, eating habits, tea–coffee and meat (oxalate rich) consumption, adequate physical activity, and all serum and urine levels—the serum levels of Na, K, Cl, phosphate, Ca, Mg, uric acid, albumin, blood urea nitrogen (BUN), creatinine and serum parathyroid hormone (PTH) as well as 24 h urine excretions of creatinine, Na, K, Cl, phosphate, Ca, Mg, citrate, oxalate, uric acid, albumin and BUN. Significant differences were found between rs16260 and the risk of nephrolithiasis. Patients having CA genotype of rs16260 CDH1 polymorphism were associated with an almost trifold increased risk for developing kidney stone than those with the AA genotype (95 % CI 1.08–7.28, OR 2.8, P = 0.033). We also found that non-A allele carriers (CC) had significantly higher nephrolithiasis risk associated with the clinicopathological characteristics including serum calcium (P = 0.027) and 24 h urinary magnesium level (P = 0.042). Moreover, we did find a directly proportional relationship between the CA genotype and serum calcium levels (P = 0.041). There was no significant difference between patients and controls in terms of the distribution of rs5030625 genotypes and alleles (P > 0.05). Likewise, no associations between the rs16260 and rs5030625 haplotypes and susceptibility to kidney stone were observed (P > 0.05). Regulatory variants of rs16260 of the CDH1 gene may confer susceptibility to nephrolithiasis. This may have important implications for understanding the pathophysiological mechanisms of the disease and suggesting novel targets for drug treatment.